Document Classification

Section Type: METHODS

Text: Fifty eligible patients were assigned to the FAM (5-fluorouracil 600 mg/m2 intravenous (i. v.) on Days 1, 8, 29, 36 ; doxorubicin 30 mg/m2 i. v. on Days 1 and 29 ; mitomycin C 10 mg/m2 i. v. on Day 1 ; every 8 weeks) and 52 to the PAM combination (cisplatin 60 mg/m2 i. v. on Days 1 and 29 ; doxorubicin 30 mg/m2 i. v. on Days 1 and 29 ; mitomycin C 10 mg/m2 i. v. on Day 1 ; every 8 weeks).